The Zacks Analyst Blog Highlights:Sanofi, Aegerion Pharmaceuticals, Shire …
As attempts to reduce expenditures rise, pharma companies may find costs unsustainable. However, competition between drug makers is bringing down prices. For example, Sanofi (NYSE: SNY-Free Report) produces Kynamro, used to treat a life-threatening … Read more on PR Newswire (press release)
Study Gives Hope of Altering Genes to Repel HIV
He said the approach was worth considering because many patients dislike the antiviral drugs and experience side effects, and because lifelong treatment can cost $ 1 million in the United States. Gene editing could be cheaper, he said. One scientific … Read more on New York Times